Heterocyclic GABA

2 A This invention relates to a method for modulating αsubtype GABAreceptors with heterocyclic compounds of formula I, and salts, solvates and prodrugs thereof. The invention further relates to novel heteocyclic compounds and pharmaceutical compositions containing said compounds. In addition the inv...

Full description

Saved in:
Bibliographic Details
Main Authors Loughhead, David Garrett, Novakovic, Sanja, O'Yang, Counde, Putman, David George, Soth, Michael
Format Patent
LanguageEnglish
Published 07.10.2008
Online AccessGet full text

Cover

More Information
Summary:2 A This invention relates to a method for modulating αsubtype GABAreceptors with heterocyclic compounds of formula I, and salts, solvates and prodrugs thereof. The invention further relates to novel heteocyclic compounds and pharmaceutical compositions containing said compounds. In addition the invention relates to the treatment of depression, an anxiety disorder, a psychiatric disorder, a learning or cognitive disorder, a sleep disorder, a convulsive or seizure disorder or pain